Title:  Sex-related Differences in Profiles and Clinical Outcomes of Inflammatory Bowel
Disease: A Systematic Review and Meta-Analysis
Version: 2 Date: 22 Oct 2024
Reviewer:  Panagiotis Tsibouris
Reviewer's report:
Abstract Data on presence of anxiety or depression should be better presented at the begining
of results As well as differences in disease location Results Could patients report the number of
biologics used? What they actually mean patients were receiving more biologics but apart from
adalimumab there was also no diffrence as reported for anti-TNFs
Title:  Sex-related Differences in Profiles and Clinical Outcomes of Inflammatory Bowel
Disease: A Systematic Review and Meta-Analysis
Version: 2 Date: 22 Oct 2024
Reviewer:  Panagiotis Tsibouris
Reviewer's report:
Abstract Data on presence of anxiety or depression should be better presented at the begining
of results As well as differences in disease location Results Could patients report the number of
biologics used? What they actually mean patients were receiving more biologics but apart from
adalimumab there was also no diffrence as reported for anti-TNFs
Please review this paper.
user
Title:  Sex-related Differences in Profiles and Clinical Outcomes of Inflammatory Bowel
Disease: A Systematic Review and Meta-Analysis
Version: 2 Date: 22 Oct 2024
Reviewer:  Panagiotis Tsibouris
Reviewer's report:
Abstract Data on presence of anxiety or depression should be better presented at the begining
of results As well as differences in disease location Results Could patients report the number of
biologics used? What they actually mean patients were receiving more biologics but apart from
adalimumab there was also no diffrence as reported for anti-TNFs
assistant